Medicine
Tablets for the treatment of cholecystitis "Danshin" (Danning Pian/ Dan Ning Pian)
The effect of the drug:
- eliminates pathogenic heat and humidity,
- adjusts the functioning of the liver,
- promotes the excretion of bile from the body
Indications for use:
- chronic cholecystitis,
- infections in the biliary tract,
- cholelithiasis in the initial stage.
Ingredients: artificial bezoar, silymarin, berberine hydrochloride, corydalis, rhubarb, dandelion, Desmodium styraxolifolia, peppermint oil.
Mode of application:
for oral use,
take 2-3 tablets 3-4 times a day.
for oral use,
take 2-3 tablets 3-4 times a day.
Contraindications: formed stones 3-5mm
Side effects: diarrhea is possible.
Side effects: diarrhea is possible.
Storage: in hermetically sealed packaging in a dry place.
Attention: the drug contains berberine hydrochloride.
Attention: the drug contains berberine hydrochloride.
Characteristics of the drug: sugar-coated tablets with light brown contents. They have a slight smell.
Xiaoyan Li Dan Pian - tablets used for inflammation of the gallbladder.
- This is a healing drug that was able to combine both the latest technology and ancient Eastern traditions.
- The drug normalizes all functions of the gallbladder, restoring the natural metabolism of cholesterol in the body.
- The drug has anti-inflammatory and choleretic properties. Its effectiveness has been proven by numerous laboratory studies and positive customer reviews.
Indications for use:
- Acute and chronic cholecystitis
- Cholangitis
- Biliary dyskinesia
- Cholelithiasis.
Pharmachologic effect:
It has an anti-inflammatory and analgesic effect, relaxes the muscles of the sphincter of Oddi, increasing the secretion of bile and normalizing the function of the gallbladder, laxative.
Instructions for use:
Take 6 tablets 3 times a day during or after meals with warm boiled water.
Тauroursodeoxycholic acid capsules Bruschettini S.r.l.(Italy)
To order this drug, write an email.
Taurous deoxycholic acid (TUDCA) is ursodeoxycholic acid combined with a taurine molecule.
Tauroursodeoxycholic acid is more effective in increasing bile concentrations of ursodeoxycholic acid (as well as lowering effects such as decreasing liver enzyme levels) than ursodeoxycholic acid alone. Presumably, this is due to the increased bioavailability of the taurine group. The process of conjugation of ursodeoxycholic acid with taurine is a rate-limiting step, and this rate-limiting step is eliminated by taking tauroursodeoxycholic acid.
Gallstones (made up of cholesterol) can be treated in a litholytic manner with bile acids, dissolving them to a size where they can be passed.
Cholesterol gallstones account for approximately 75% of all hepatic gallstones (in Western countries) and are the only form of gallstones that can be dissolved by bile acids.
Tauroursodeoxycholic acid is more effective in increasing bile concentrations of ursodeoxycholic acid (as well as lowering effects such as decreasing liver enzyme levels) than ursodeoxycholic acid alone. Presumably, this is due to the increased bioavailability of the taurine group. The process of conjugation of ursodeoxycholic acid with taurine is a rate-limiting step, and this rate-limiting step is eliminated by taking tauroursodeoxycholic acid.
Gallstones (made up of cholesterol) can be treated in a litholytic manner with bile acids, dissolving them to a size where they can be passed.
Cholesterol gallstones account for approximately 75% of all hepatic gallstones (in Western countries) and are the only form of gallstones that can be dissolved by bile acids.
Gallstones may become opaque, indicating their inability to dissolve. The opacity is due to calcium deposition in the cholesterol gallstone, making it resistant to the cholelitholytic effects of bile acids. Opaque gallstones are either black (about 20% of the total, composed of calcium phosphate and/or carbonate with insoluble bilirubin pigment and cholesterol) or brown (about 5% of the total, composed of calcium bilirubinate, calcium palmitate, stearate and cholesterol ).
It should be noted that typically about 10% of people with gallstones respond to tauroursodeoxycholic acid. This treatment is suitable for people who are contraindicated for surgery and have small (5 mm or smaller in diameter) non-calcium gallstones that are high in cholesterol.
It should be noted that typically about 10% of people with gallstones respond to tauroursodeoxycholic acid. This treatment is suitable for people who are contraindicated for surgery and have small (5 mm or smaller in diameter) non-calcium gallstones that are high in cholesterol.
The dosage and course of administration are prescribed to everyone individually: as a prophylaxis after surgery with preservation of the gallbladder - based on ultrasound results, without surgery - based on the results of computed tomography.
Packaging: 20 capsules, 250 mg each
Packaging: 20 capsules, 250 mg each
